Millennium Pharmacon International
PT Millennium Pharmacon International Tbk engages in the distribution of prescription and non-prescription medicines and medical devices in Indonesia. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium… Read more
Millennium Pharmacon International (SDPC) - Total Assets
Latest total assets as of September 2025: Rp1.90 Trillion IDR
Based on the latest financial reports, Millennium Pharmacon International (SDPC) holds total assets worth Rp1.90 Trillion IDR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Millennium Pharmacon International - Total Assets Trend (2000–2024)
This chart illustrates how Millennium Pharmacon International’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Millennium Pharmacon International - Asset Composition Analysis
Current Asset Composition (December 2024)
Millennium Pharmacon International's total assets of Rp1.90 Trillion consist of 88.3% current assets and 11.7% non-current assets.
| Asset Category | Amount (IDR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 3.0% |
| Accounts Receivable | Rp741.59 Billion | 41.9% |
| Inventory | Rp567.73 Billion | 32.0% |
| Property, Plant & Equipment | Rp111.42 Billion | 6.3% |
| Intangible Assets | Rp7.78 Billion | 0.4% |
| Goodwill | Rp0.00 | 0.0% |
Asset Composition Trend (2000–2024)
This chart illustrates how Millennium Pharmacon International's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Millennium Pharmacon International's current assets represent 88.3% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 3.0% of total assets in 2024, down from 6.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
- Asset Diversification: The largest asset category is accounts receivable at 41.9% of total assets.
Millennium Pharmacon International Competitors by Total Assets
Key competitors of Millennium Pharmacon International based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.45 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
Millennium Pharmacon International - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Millennium Pharmacon International generates 2.21x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Millennium Pharmacon International generates $ 0.95 in net profit.
Millennium Pharmacon International - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.11 | 1.13 | 1.14 |
| Quick Ratio | 0.74 | 0.73 | 0.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rp159.57 Billion | Rp 182.93 Billion | Rp 125.63 Billion |
Millennium Pharmacon International - Advanced Valuation Insights
This section examines the relationship between Millennium Pharmacon International's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.59 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 8.1% |
| Total Assets | Rp1.77 Trillion |
| Market Capitalization | $1.76 Million USD |
Valuation Analysis
Below Book Valuation: The market values Millennium Pharmacon International's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Millennium Pharmacon International's assets grew by 8.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Millennium Pharmacon International (2000–2024)
The table below shows the annual total assets of Millennium Pharmacon International from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Rp1.77 Trillion | +8.06% |
| 2023-12-31 | Rp1.64 Trillion | +16.99% |
| 2022-12-31 | Rp1.40 Trillion | +16.17% |
| 2021-12-31 | Rp1.21 Trillion | +3.57% |
| 2020-12-31 | Rp1.16 Trillion | -5.36% |
| 2019-12-31 | Rp1.23 Trillion | +3.18% |
| 2018-12-31 | Rp1.19 Trillion | +27.17% |
| 2017-12-31 | Rp938.01 Billion | +27.89% |
| 2016-12-31 | Rp733.44 Billion | +15.83% |
| 2015-12-31 | Rp633.22 Billion | +19.48% |
| 2014-12-31 | Rp529.99 Billion | +12.36% |
| 2013-12-31 | Rp471.68 Billion | +22.32% |
| 2012-12-31 | Rp385.61 Billion | +19.21% |
| 2011-12-31 | Rp323.47 Billion | +16.98% |
| 2010-12-31 | Rp276.52 Billion | +3.17% |
| 2009-12-31 | Rp268.01 Billion | -13.17% |
| 2008-12-31 | Rp308.66 Billion | +32.98% |
| 2007-12-31 | Rp232.11 Billion | +32.25% |
| 2006-12-31 | Rp175.52 Billion | +8.73% |
| 2005-12-31 | Rp161.43 Billion | +18.01% |
| 2004-12-31 | Rp136.79 Billion | +17.52% |
| 2003-12-31 | Rp116.40 Billion | +7.51% |
| 2002-12-31 | Rp108.27 Billion | +28.10% |
| 2001-12-31 | Rp84.52 Billion | -25.45% |
| 2000-12-31 | Rp113.38 Billion | -- |